Literature DB >> 6107116

The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability.

I Hindmarch, A C Gudgeon.   

Abstract

1 Laboratory tests of psychomotor performance and 'on road' assessments of car handling ability were made following repeated doses of clobazam 10 mg three times daily, lorazepam 1 mg three times daily and matching placebo 1 capsule three times daily. 2 Both active compounds produced on impairment, compared to placebo, in some mental arithmetic and letter cancellation tasks, but these effects were neither widespread nor consistent. 3 Lorazepam produced a significant impairment of car driving tasks and analogue rating scales of subjective alertness. The pronounced sedative activity of the drug was also shown in the verbal reports of side effects and in indices of early morning sedation derived from the Leeds Sleep Evaluation Questionnaire. 4 Clobazam did not produce either the objective, or the subjective impairment of performance and alertness found with lorazepam. 5 The results taken as a whole show important differences between the 1,4 benzodiazepine, lorazepam, and the 1,5 benzodiazepine, clobazam, in their effects on the integrity of psychomotor performance related to car driving ability.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6107116      PMCID: PMC1430040          DOI: 10.1111/j.1365-2125.1980.tb01731.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  29 in total

1.  Effects of four commonly-used tranquillizers on low-speed driving performance tests.

Authors:  T A Betts; A B Clayton; G M Mackay
Journal:  Br Med J       Date:  1972-12-09

2.  The effect of lorazepam on anxious insomniacs' sleep as recorded in the home environment.

Authors:  G Globus; E Phoebus; J Humphries; R Boyd; D Gaffney; S Gaffney
Journal:  J Clin Pharmacol       Date:  1974-04       Impact factor: 3.126

3.  Central nervous system and cardiovascular effects of lorazepam in man.

Authors:  H W Elliott; N Nomof; G Navarro; H W Ruelius; J A Knowles; W H Comer
Journal:  Clin Pharmacol Ther       Date:  1971 May-Jun       Impact factor: 6.875

4.  The residual effects of flurazepam.

Authors:  A J Bond; M H Lader
Journal:  Psychopharmacologia       Date:  1973-09-28

5.  Clinical pharmacological studies on lorazepam.

Authors:  P Turner
Journal:  Curr Med Res Opin       Date:  1973       Impact factor: 2.580

6.  Lorazepam--a study in psychomotor depression.

Authors:  T V Harry; D J Richards
Journal:  Br J Clin Pract       Date:  1972-08

7.  Preliminary studies on the central effects of lorazepam, a new benzodiazepine.

Authors:  A Hedges; P Turner; T V Harry
Journal:  J Clin Pharmacol New Drugs       Date:  1971 Nov-Dec

8.  Lorazepam on visuo-motor co-ordination and visual function in man.

Authors:  R W Bell; D S Dickie; J Stewart-Jones; P Turner
Journal:  J Pharm Pharmacol       Date:  1973-01       Impact factor: 3.765

9.  Disposition of 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam) in humans. Determination of the drug by electron capture gas chromatography.

Authors:  J A Knowles; W H Comer; H W Ruelius
Journal:  Arzneimittelforschung       Date:  1971-07

10.  Wy 4036 (lorazepam): a study of its use in premedication.

Authors:  W Norris; P G Wallace
Journal:  Br J Anaesth       Date:  1971-08       Impact factor: 9.166

View more
  32 in total

Review 1.  A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults.

Authors:  Emily Beth Devine; Zafar Hakim; Jesse Green
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers.

Authors:  Ian Hindmarch; Leanne Trick; Fran Ridout
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

Review 3.  Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.

Authors:  Christopher J Edgar; Edward F Pace-Schott; Keith A Wesnes
Journal:  Hum Psychopharmacol       Date:  2009-07       Impact factor: 1.672

Review 4.  Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.

Authors:  Jose de Leon; Edoardo Spina; Francisco J Diaz
Journal:  Ther Drug Monit       Date:  2013-02       Impact factor: 3.681

5.  Nomifensine, clobazam and HOE 8476: effects on aspects of psychomotor performance and cognitive ability.

Authors:  A C Parrott; I Hindmarch; P D Stonier
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

6.  Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers.

Authors:  A Patat; M C Perault; B Vandel; N Ulliac; I Zieleniuk; P Rosenzweig
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

Review 7.  Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review.

Authors:  Toni M Rudisill; Motao Zhu; George A Kelley; Courtney Pilkerton; Brandon R Rudisill
Journal:  Accid Anal Prev       Date:  2016-08-29

8.  Gabapentin as an antiepileptic drug in man.

Authors:  P Crawford; E Ghadiali; R Lane; L Blumhardt; D Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

9.  Loprazolam (HR158) and flurazepam with ethanol compared on tests of psychomotor ability.

Authors:  I Hindmarch; A C Gudgeon
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  GABA-ergic control of visual perception in healthy volunteers: effects of midazolam, a benzodiazepine, on spatio-temporal contrast sensitivity.

Authors:  O Blin; D Mestre; O Paut; J L Vercher; C Audebert
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.